1.
Molecular Docking Human Plasma Kallikrein to Prevent Acute Respiratory Distress Syndrome(ARDS) in COVID-19 Patient. Indian Journal of Forensic Medicine & Toxicology [Internet]. 2021 Aug. 16 [cited 2026 May 6];15(4):1146-51. Available from: https://medicopublication.com/index.php/ijfmt/article/view/16860